Prempro: Clinical Trials

4 trials of Prempro, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 31Completed 1

Follow Prempro: new trials by email Literature Review of Prempro trials Research Report on Prempro

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis
bazedoxifene 20 mg/ conjugated estrogens 0.45 mg, bazedoxifene 20 mg/ conjugated estrogens 0.625 mg, bazedoxifene 20 mg - Menopause, Osteoporosis
Phase 3CompletedPfizer18862009-01-012014-04-08
Bioidentical 'Natural' Hormone Evaluation in Early Menopause
Estradiol , estriol , progesterone, estradiol, progesterone, estriol, progesterone - Menopause
Phase 2TerminatedJeanne Drisko, MD, CNS, FACN212006-02-012018-07-06
The Women's Health Initiative Memory Study (The WHIMS Study)
Estrogen hormone therapy, Estrogen plus progesterone hormone therapy, Placebo - Dementia Syndromes
CompletedNational Heart, Lung, and Blood Institute (NHLBI)75251996-01-012015-10-19
Hormone Replacement in Menopausal Women With Epilepsy
prempro - Menopause, Epilepsy
Phase 2CompletedNational Institute of Neurological Disorders and Stroke (NINDS)1252006-05-15

Conditions studied

Epilepsy (1)  ·  Osteoporosis (1)  ·  Seizures (1)

Sponsors

Jeanne Drisko, MD, CNS, FACN (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  Pfizer (1)

Countries

United States (4)  ·  Argentina (1)  ·  Australia (1)  ·  Chile (1)  ·  Colombia (1)  ·  Denmark (1)  ·  Finland (1)  ·  Hungary (1)  ·  Mexico (1)  ·  New Zealand (1)  ·  Norway (1)  ·  Poland (1)

Top investigators

Jeanne A Drisko, MD (1)  ·  Sally A. Shumaker, PhD (1)

Results publications

PMID 23480899, PMID 23635731, PMID 24438370, PMID 26137952, PMID 31685499, PMID 33710263, PMID 41678876

NIH funding

N01WH44221 (1)